|
US5298262A
(en)
*
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
|
US5346702A
(en)
*
|
1992-12-04 |
1994-09-13 |
Sterling Winthrop Inc. |
Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
|
|
US5336507A
(en)
*
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US5503723A
(en)
*
|
1995-02-08 |
1996-04-02 |
Eastman Kodak Company |
Isolation of ultra small particles
|
|
US5500204A
(en)
*
|
1995-02-10 |
1996-03-19 |
Eastman Kodak Company |
Nanoparticulate diagnostic dimers as x-ray contrast agents for blood pool and lymphatic system imaging
|
|
US5747001A
(en)
*
|
1995-02-24 |
1998-05-05 |
Nanosystems, L.L.C. |
Aerosols containing beclomethazone nanoparticle dispersions
|
|
CA2213638C
(en)
*
|
1995-02-24 |
2004-05-04 |
Nanosystems L.L.C. |
Aerosols containing nanoparticle dispersions
|
|
US5766629A
(en)
|
1995-08-25 |
1998-06-16 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
|
US5834025A
(en)
*
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
|
US20050267302A1
(en)
*
|
1995-12-11 |
2005-12-01 |
G.D. Searle & Co. |
Eplerenone crystalline form exhibiting enhanced dissolution rate
|
|
US5976573A
(en)
*
|
1996-07-03 |
1999-11-02 |
Rorer Pharmaceutical Products Inc. |
Aqueous-based pharmaceutical composition
|
|
US6071904A
(en)
*
|
1996-12-11 |
2000-06-06 |
Alcon Laboratories, Inc. |
Process for manufacturing ophthalmic suspensions
|
|
WO1998035666A1
(en)
*
|
1997-02-13 |
1998-08-20 |
Nanosystems Llc |
Formulations of nanoparticle naproxen tablets
|
|
US6045829A
(en)
*
|
1997-02-13 |
2000-04-04 |
Elan Pharma International Limited |
Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
|
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
|
AU7133898A
(en)
*
|
1997-04-18 |
1998-11-13 |
Vertex Pharmaceuticals Incorporated |
Nanosized aspartyl protease inhibitors
|
|
WO1998048847A1
(en)
*
|
1997-04-25 |
1998-11-05 |
Nycomed Imaging As |
Nanoparticle composition containing iodinated x-ray contrast agent as stabilizer for thermal sterilization
|
|
UA72189C2
(ru)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Водные суспензии субмикронной формы эфиров 9-гидроксирисперидона жирных кислот
|
|
US6207392B1
(en)
|
1997-11-25 |
2001-03-27 |
The Regents Of The University Of California |
Semiconductor nanocrystal probes for biological applications and process for making and using such probes
|
|
US7816403B2
(en)
|
1998-09-08 |
2010-10-19 |
University Of Utah Research Foundation |
Method of inhibiting ATF/CREB and cancer cell growth and pharmaceutical compositions for same
|
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
US20070160675A1
(en)
*
|
1998-11-02 |
2007-07-12 |
Elan Corporation, Plc |
Nanoparticulate and controlled release compositions comprising a cephalosporin
|
|
CN100444830C
(zh)
*
|
1998-11-02 |
2008-12-24 |
伊兰公司，Plc |
多颗粒改进释放组合物
|
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
|
US6969529B2
(en)
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
|
EA008449B1
(ru)
*
|
1999-12-08 |
2007-06-29 |
Фармация Корпорейшн |
Кристаллическая форма эплеренона
|
|
BR0008060A
(pt)
*
|
1999-12-08 |
2002-02-05 |
Pharmacia Corp |
Composições inibidoras de ciclooxigenase-2 tendo rápido inìcio de eficácia terapêutica
|
|
US20030083493A1
(en)
*
|
1999-12-08 |
2003-05-01 |
Barton Kathleen P. |
Eplerenone drug substance having high phase purity
|
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
US6495164B1
(en)
*
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
MY120279A
(en)
*
|
2000-05-26 |
2005-09-30 |
Pharmacia Corp |
Use of a celecoxib composition for fast pain relief
|
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
AU2002239504A1
(en)
*
|
2000-12-06 |
2002-06-18 |
Pharmacia Corporation |
Laboratory scale milling process
|
|
UA80393C2
(ru)
*
|
2000-12-07 |
2007-09-25 |
Алтана Фарма Аг |
Фармацевтическая композиция, которая содержит ингибитор фдэ 4, диспергированный в матрице
|
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6869617B2
(en)
*
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
|
DE60203506T2
(de)
*
|
2001-06-22 |
2006-02-16 |
Marie Lindner |
Screening-verfahren mit hohem durchsatz (hts) unter verwendung von labormühlen oder microfluidics
|
|
US7758890B2
(en)
|
2001-06-23 |
2010-07-20 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
DE60217367T2
(de)
*
|
2001-09-19 |
2007-10-18 |
Elan Pharma International Ltd. |
Nanopartikelzusammensetzungen enthaltend insulin
|
|
BR0212822A
(pt)
*
|
2001-09-25 |
2005-08-30 |
Pharmacia Corp |
Formas cristalinas de n-(2-hidroxiacetil)-5-(4-piperdil)-4-(4-pirimidinil)-3-(4-clo rofenil)pirazol e composições farmacêuticas contendo as mesmas
|
|
CA2461349C
(en)
|
2001-09-26 |
2011-11-29 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
US6908626B2
(en)
*
|
2001-10-12 |
2005-06-21 |
Elan Pharma International Ltd. |
Compositions having a combination of immediate release and controlled release characteristics
|
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
US20030152519A1
(en)
*
|
2001-11-07 |
2003-08-14 |
Reinhard Koenig |
Methods for vascular imaging using nanoparticulate contrast agents
|
|
EA200400782A1
(ru)
*
|
2001-12-06 |
2005-08-25 |
Рэнбакси Лабораториз Лимитед |
Композиция изотретиноина с измельчением компонентов до степени наночастиц
|
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
|
WO2003066021A2
(en)
|
2002-02-04 |
2003-08-14 |
Elan Pharma International, Ltd. |
Drug nanoparticles with lysozyme surface stabiliser
|
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
|
MY140561A
(en)
*
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
|
CA2479735C
(en)
*
|
2002-03-20 |
2011-05-17 |
Elan Pharma International Ltd. |
Fast dissolving dosage forms having reduced friability
|
|
JP4842514B2
(ja)
*
|
2002-03-20 |
2011-12-21 |
エラン ファーマ インターナショナル，リミティド |
血管新生抑制剤のナノ粒子組成物
|
|
AU2003224808A1
(en)
*
|
2002-03-28 |
2003-10-13 |
Imcor Pharmaceutical Company |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
|
US9101540B2
(en)
*
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
|
ES2380318T3
(es)
|
2002-04-12 |
2012-05-10 |
Alkermes Pharma Ireland Limited |
Formulaciones nanoparticulares de megestrol
|
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
ATE419835T1
(de)
*
|
2002-05-06 |
2009-01-15 |
Elan Pharma Int Ltd |
Nystatin-nanopartikelzusammensetzungen
|
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US7348298B2
(en)
*
|
2002-05-30 |
2008-03-25 |
Ashland Licensing And Intellectual Property, Llc |
Enhancing thermal conductivity of fluids with graphite nanoparticles and carbon nanotube
|
|
JP4533134B2
(ja)
*
|
2002-06-10 |
2010-09-01 |
エラン ファーマ インターナショナル，リミティド |
ナノ粒子ポリコサノール製剤および新規なポリコサノールの組合せ
|
|
US20040258757A1
(en)
*
|
2002-07-16 |
2004-12-23 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
|
ES2355723T3
(es)
*
|
2002-09-11 |
2011-03-30 |
Elan Pharma International Limited |
Composiciones de agente activo en nanopartículas estabilizadas en gel.
|
|
WO2004032980A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
|
JP4776233B2
(ja)
*
|
2002-11-12 |
2011-09-21 |
エラン ファーマ インターナショナル，リミティド |
摩損しにくくかつプルランを含む速崩壊性固形製剤
|
|
US20040173696A1
(en)
*
|
2002-12-17 |
2004-09-09 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
|
WO2004078162A1
(en)
*
|
2003-01-31 |
2004-09-16 |
Elan Pharma International Ltd. |
Nanoparticulate topiramate formulations
|
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
|
US20100297252A1
(en)
*
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
|
US7208486B2
(en)
|
2003-03-07 |
2007-04-24 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
|
US7235543B2
(en)
|
2003-03-07 |
2007-06-26 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
|
EP1606261B1
(en)
|
2003-03-10 |
2009-11-04 |
Nycomed GmbH |
Novel process for the preparation of roflumilast
|
|
WO2004105809A1
(en)
*
|
2003-05-22 |
2004-12-09 |
Elan Pharma International Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
|
JP2007501839A
(ja)
*
|
2003-08-08 |
2007-02-01 |
エラン ファーマ インターナショナル リミテッド |
新規メタキサロン組成物
|
|
EP1684725A1
(en)
*
|
2003-10-31 |
2006-08-02 |
Elan Pharma International Limited |
Novel nimesulide compositions
|
|
JP4787165B2
(ja)
*
|
2003-11-05 |
2011-10-05 |
エラン ファーマ インターナショナル，リミティド |
表面安定剤としてペプチドを有するナノ粒子組成物
|
|
WO2005060648A2
(en)
*
|
2003-12-16 |
2005-07-07 |
Ashland Inc. |
Lubricants with enhanced thermal conductivity containing nanomaterial
|
|
WO2006083326A2
(en)
|
2004-08-07 |
2006-08-10 |
Cabot Corporation |
Gas dispersion manufacture of nanoparticulates and nanoparticulate-containing products and processing thereof
|
|
US20060083694A1
(en)
|
2004-08-07 |
2006-04-20 |
Cabot Corporation |
Multi-component particles comprising inorganic nanoparticles distributed in an organic matrix and processes for making and using same
|
|
BRPI0518187A
(pt)
*
|
2004-11-16 |
2008-11-04 |
Elan Pharma Int Ltd |
formulações de olanzapina em nanopartìcula injetáveis
|
|
US20090155331A1
(en)
*
|
2005-11-16 |
2009-06-18 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
|
UA89513C2
(ru)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабильная композиция из наночастичек ралоксифена гидрохлорида
|
|
AU2005316473B2
(en)
*
|
2004-12-15 |
2011-07-14 |
Elan Pharma International Ltd. |
Nanoparticulate tacrolimus formulations
|
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
|
US20060165806A1
(en)
*
|
2005-01-06 |
2006-07-27 |
Elan Pharma International Limited |
Nanoparticulate candesartan formulations
|
|
MX2007009915A
(es)
|
2005-02-15 |
2007-11-06 |
Elan Pharma Int Ltd |
Formulaciones en aerosol e inyectables de benzodiazepina nanoparticulada.
|
|
WO2006096462A1
(en)
*
|
2005-03-03 |
2006-09-14 |
Elan Pharma International Limited |
Nanoparticulate compositions of heterocyclic amide derivatives
|
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
|
BRPI0606283A2
(pt)
*
|
2005-03-16 |
2009-06-09 |
Elan Pharma Int Ltd |
formulações de antagonista de receptor de leucotrieno/corticosteróide em nanopartìcula
|
|
WO2006097456A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Nycomed Gmbh |
Taste masked dosage form containing roflumilast
|
|
WO2006102117A1
(en)
*
|
2005-03-17 |
2006-09-28 |
Elan Pharma International Limited |
Nanoparticulate biphosphonate compositions
|
|
MX2007011772A
(es)
*
|
2005-03-23 |
2007-12-05 |
Elan Pharma Int Ltd |
Formulaciones de antihistaminico y corticosteroide de materia en nanoparticulas.
|
|
WO2006110811A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Nanoparticulate quinazoline derivative formulations
|
|
WO2006110802A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
|
WO2006110809A2
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
|
US20090081297A1
(en)
*
|
2005-04-27 |
2009-03-26 |
Cook Robert O |
Use of surface tension reducing agents in aerosol formulations
|
|
US20110064803A1
(en)
*
|
2005-05-10 |
2011-03-17 |
Elan Pharma International Limited. |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
|
AU2006336417A1
(en)
*
|
2005-05-10 |
2007-08-02 |
Elan Pharma International, Limited |
Nanoparticulate clopidogrel formulations
|
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
|
KR20080017065A
(ko)
*
|
2005-06-03 |
2008-02-25 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 아세트아미노펜 제제
|
|
WO2006133045A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
|
CN101232870A
(zh)
*
|
2005-06-03 |
2008-07-30 |
伊兰制药国际有限公司 |
纳米微粒甲磺酸伊马替尼制剂
|
|
CA2612994A1
(en)
|
2005-06-08 |
2006-12-08 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cefditoren
|
|
WO2006135689A2
(en)
*
|
2005-06-09 |
2006-12-21 |
Elan Pharma International, Limited |
Nanoparticulate ebastine formulations
|
|
EP1898911A1
(en)
*
|
2005-06-13 |
2008-03-19 |
Elan Pharma International Limited |
Nanoparticulate clopidogrel and aspirin combination formulations
|
|
WO2006138421A2
(en)
*
|
2005-06-15 |
2006-12-28 |
Elan Pharma International Limited |
Nanoparticulate azelnidipine formulations
|
|
US20070015719A1
(en)
*
|
2005-07-07 |
2007-01-18 |
Elan Pharma International Limited |
Nanoparticulate clarithromycin formulations
|
|
CA2622200A1
(en)
*
|
2005-09-13 |
2007-03-22 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
|
WO2007035348A2
(en)
|
2005-09-15 |
2007-03-29 |
Elan Pharma International, Limited |
Nanoparticulate aripiprazole formulations
|
|
WO2007038420A2
(en)
*
|
2005-09-26 |
2007-04-05 |
Aeras Global Tb Vaccine Foundation |
Process for stabilization of bacterial cells
|
|
EP1945736A4
(en)
*
|
2005-10-27 |
2010-08-25 |
Univ Clemson |
FLUORESCENT CARBONNANE PARTICLES
|
|
EP1959966B1
(en)
|
2005-11-28 |
2020-06-03 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone formulations and methods for the making and use thereof
|
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
EP2040675A1
(en)
*
|
2006-05-30 |
2009-04-01 |
Elan Pharma International Limited |
Nanoparticulate posaconazole formulations
|
|
EP2037888A2
(en)
*
|
2006-06-26 |
2009-03-25 |
Mutual Pharmaceutical Company, Inc. |
Active agent formulations, methods of making, and methods of use
|
|
WO2008008733A2
(en)
*
|
2006-07-10 |
2008-01-17 |
Elan Pharma International Ltd. |
Nanoparticulate sorafenib formulations
|
|
CL2007002689A1
(es)
|
2006-09-18 |
2008-04-18 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
|
|
DE102006054013A1
(de)
*
|
2006-11-16 |
2008-05-21 |
Clariant International Ltd. |
Beschichtungsmassen enthaltend reaktive Esterwachse und Mischoxid-Nanopartikel
|
|
JP2010510988A
(ja)
|
2006-11-28 |
2010-04-08 |
マリナス ファーマシューティカルズ |
ナノ粒子製剤とその製造方法およびその利用
|
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
|
US8642062B2
(en)
|
2007-10-31 |
2014-02-04 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a slow dissolving polymer
|
|
US20090238867A1
(en)
*
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
|
KR20110007095A
(ko)
*
|
2008-03-21 |
2011-01-21 |
엘란 파마 인터내셔널 리미티드 |
이마티니브의 부위-특이적 전달을 위한 조성물 및 사용방법
|
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
|
TWI580441B
(zh)
*
|
2008-09-19 |
2017-05-01 |
愛爾康研究有限公司 |
穩定的藥學次微米懸浮液及其形成方法
|
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
|
US20120065221A1
(en)
|
2009-02-26 |
2012-03-15 |
Theraquest Biosciences, Inc. |
Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
|
|
WO2010102065A1
(en)
*
|
2009-03-05 |
2010-09-10 |
Bend Research, Inc. |
Pharmaceutical compositions of dextran polymer derivatives
|
|
US7828996B1
(en)
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
|
US20100291221A1
(en)
*
|
2009-05-15 |
2010-11-18 |
Robert Owen Cook |
Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
|
|
US20100316725A1
(en)
|
2009-05-27 |
2010-12-16 |
Elan Pharma International Ltd. |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
|
WO2010137335A1
(ja)
*
|
2009-05-29 |
2010-12-02 |
江崎グリコ株式会社 |
α－リポ酸ナノ粒子を含有する、ターンオーバー促進用組成物
|
|
AR077692A1
(es)
|
2009-08-06 |
2011-09-14 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
|
|
PL2586426T3
(pl)
|
2009-12-03 |
2016-01-29 |
Alcon Res Ltd |
Zawiesiny zawierające nanocząsteczkowe polimery karboksywinylowe
|
|
WO2011146583A2
(en)
|
2010-05-19 |
2011-11-24 |
Elan Pharma International Limited |
Nanoparticulate cinacalcet formulations
|
|
JP6122003B2
(ja)
|
2011-07-22 |
2017-04-26 |
ケモセントリックス， インコーポレイテッド |
４−ｔｅｒｔ−ブチル−Ｎ−［４−クロロ−２−（１−オキシ−ピリジン−４−カルボニル）−フェニル］−ベンゼンスルホンアミドのナトリウム塩の結晶形
|
|
JP6166721B2
(ja)
|
2011-07-22 |
2017-07-19 |
ケモセントリックス， インコーポレイテッド |
４−ｔｅｒｔ−ブチル−Ｎ−［４−クロロ−２−（１−オキシ−ピリジン−４−カルボニル）−フェニル］−ベンゼンスルホンアミドのナトリウム塩の多形
|
|
EA027972B1
(ru)
|
2011-09-01 |
2017-09-29 |
Глэксо Груп Лимитед |
Новая кристаллическая форма
|
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
US10688041B2
(en)
|
2012-05-03 |
2020-06-23 |
Kala Pharmaceuticals, Inc. |
Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
|
|
AU2013256130B2
(en)
|
2012-05-03 |
2017-12-21 |
Alcon Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
JP2017502950A
(ja)
|
2013-12-11 |
2017-01-26 |
ユニバーシティー オブ マサチューセッツＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｍａｓｓａｃｈｕｓｅｔｔｓ |
サルモネラＴ３ＳＳエフェクタータンパク質（ＳｉｐＡ）を使用した疾患を治療するための組成物および方法
|
|
RS61731B1
(sr)
|
2014-06-25 |
2021-05-31 |
Glaxosmithkline Ip Dev Ltd |
Kristalne soli (s)-6-((1-acetilpiperidin-4-il)amino)-n-(3-(3,4-dihidroizohinolin-2(1h)-il)-2-hidroksipropil)pirimidin-4-karboksamida
|
|
EP3191480A1
(en)
|
2014-09-08 |
2017-07-19 |
GlaxoSmithKline Intellectual Property Development Limited |
Crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-n-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide
|
|
US10166197B2
(en)
|
2015-02-13 |
2019-01-01 |
St. John's University |
Sugar ester nanoparticle stabilizers
|
|
CN107709344B
(zh)
|
2015-05-01 |
2022-07-15 |
共晶制药股份有限公司 |
用于治疗黄病毒科病毒和癌症的核苷类似物
|
|
KR20180082457A
(ko)
|
2015-10-16 |
2018-07-18 |
마리누스 파마슈티컬스 인코포레이티드 |
나노입자들을 포함하는 주사용 뉴로스테로이드 제제들
|
|
MX2019001669A
(es)
|
2016-08-11 |
2019-09-27 |
Ovid Therapeutics Inc |
Metodos y composiciones para el tratamiento de trastornos epilepticos.
|
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
|
US11266662B2
(en)
|
2018-12-07 |
2022-03-08 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of postpartum depression
|
|
CA3145923A1
(en)
|
2019-08-05 |
2021-02-11 |
David Czekai |
Ganaxolone for use in treatment of status epilepticus
|
|
WO2021087359A1
(en)
|
2019-11-01 |
2021-05-06 |
Aquestive Therapeutics, Inc. |
Prodrug compositions and methods of treatment
|
|
BR112022008784A2
(pt)
|
2019-11-14 |
2022-07-26 |
Aquestive Therapeutics Inc |
Composições multimodais e métodos de tratamento
|
|
JP2023503928A
(ja)
|
2019-12-06 |
2023-02-01 |
マリナス ファーマシューティカルズ， インコーポレイテッド |
結節性硬化症の治療での使用のためのガナキソロン
|
|
JP2024505429A
(ja)
|
2021-01-15 |
2024-02-06 |
アクエスティブ セラピューティクス インコーポレイテッド |
プロドラッグ組成物及び治療の方法
|